Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706638 · ClinicalTrials.gov registry record · NA
Daily vs Intermittent Iron Therapy in Pregnancy
A NA study of Iron Deficiency Anemia of Pregnancy, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT03706638: Completed NA study of Iron Deficiency Anemia of Pregnancy, sponsored by UConn Health.
NCT03706638 is a NA study of Iron Deficiency Anemia of Pregnancy that has completed, run by UConn Health. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03706638, a NA study of Iron Deficiency Anemia of Pregnancy, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized non inferiority trial to evaluate the response to iron therapy in the standard daily vs. intermittent (three-four times a week on nonconsecutive days) groups by using hematological markers (hemoglobin, hematocrit, transferrin, hepcidin, ferritin, human soluble transferrin receptor). The secondary outcome is to evaluate gastrointestinal discomfort and adherence to therapy between two treatment groups.
Primary Outcome
Hematologic values of hemoglobin, hematocrit, transferrin, hepcidin, human soluble transferrin receptor and ferritin.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ferrous Sulfate
Study Locations (1)
Connecticut
- UConn Health - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2020-03-23 |
| Phase | NA |
What the finished NCT03706638 record still lists
NCT03706638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Iron Deficiency Anemia of Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Ferrous Sulfate is the first listed.
NCT03706638 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03706638 about?
NCT03706638 is a clinical study titled "Daily vs Intermittent Iron Therapy in Pregnancy". This is a randomized non inferiority trial to evaluate the response to iron therapy in the standard daily vs. intermittent (three-four times a week on nonconsecutive days) groups by using hematological markers (hemoglobin, hematocrit, transferrin, hepcidin, ferritin, human soluble transferrin recept...
What is the current status of trial NCT03706638?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-10-25. Estimated completion is 2020-03-23.
What conditions does trial NCT03706638 study?
This clinical trial studies the following conditions: Iron Deficiency Anemia of Pregnancy.
What interventions are being tested in trial NCT03706638?
The interventions under investigation include: Ferrous Sulfate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03706638?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03706638 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Iron Deficiency Anemia of Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03706638's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI